136058-64-5

Upstream product

• 98-89-5 Cyclohexanecarboxylic acid 
• 845782-67-4 (+/-)-2-(cyclohexanecarbonyl-amino)-3-oxo-butyric acid methyl ester 
• 845782-68-5 methyl 2-cyclohexyl-5-methyloxazole-4-carboxylate 
• 690684-25-4 2-cyclohexyl-4,5-dimethyl-oxazole-3-oxide 
• 61152-00-9 2-cyclohexyl-5-methyl-oxazole-4-carboxylic acid ethyl ester 
• 61152-04-3 2-cyclohexyl-5-methyl-oxazole-4-carboxylic acid 
• 51655-86-8 2-cyclohexyl-5-methyl-oxazole-4-carbonyl chloride 
• 2719-27-9 cyclohexanylcarbonyl chloride 
• 61151-95-9 2-cyclohexanecarbonylamino-3-oxo-butyric acid ethyl ester 
• 89724-31-2 2-Cyclohexyl-4-hydroxymethyl-5-methyloxazole 

Downstream Products

• 108192-92-3 (2-cyclohexyl-5-methyl-oxazol-4-yl)acetonitrile 
• 89724-32-3 2-Cyclohexyl-4-carboxymethyl-5-methyloxazole 

Relevant academic research and scientific papers

Synthesis and evaluation of a novel series of 2,7-substituted-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives as selective peroxisome proliferator-activated receptor γ partial agonists

A novel series of 7-substituted-2-[3-(2-furyl)acryloyl]-6-tetrazolyl-1,2,3,4-tetrahydroisoquinoline derivatives were synthesized to clarify structure–activity relationships for peroxisome proliferator-activated receptor γ (PPARγ) partial agonist activity

SUBSTITUTED 4-ALKOXYOXAZOL DERIVATIVES AS PPAR AGONISTS

The present invention relates to compounds of formula (I) wherein R1 to R8 and n are as defined in the description and claims, and pharmaceutically acceptable salts and esters thereof. The compounds are useful for the treatment of diseases such as diabetes.

Oxazolidinedione hypoglycemic agents

Compounds of the formulae STR1 where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.

Oxazolidinedione hypoglycemic agents

Compounds of the formulae where R is cycloalkyl or aryl; R1 is alkyl, X is O or C=O; A is O or S; and B is N or CH are useful as hypoglycemic agents.